This Week in Pediatric Oncology

This Week in Pediatric Oncology header image 1

Entries Tagged as 'Uncategorized'

TWiPO #62 - Interview with Dr. Uri Tabori

May 25th, 2017 · Comments

TWiPO hosts and cohosts interview Dr. Uri Tabori about the challenges that are unique to pediatric brain tumors, and how preventative treatment and early diagnosis can be largely beneficial.  

00:0000:00

Tags: Uncategorized

TWIPO #61 - Interview with Dr. Matthew Breen

May 25th, 2017 · Comments

TWIPO hosts and cohosts interview Dr. Matthew Breen, NC State Veterinary Medicine, to explore the question "Can dogs teach us new tricks when it comes to cancer treatment?"

00:0000:00

Tags: Uncategorized

TWIPO #60 - Interview with Dr. Josua Mendell

May 25th, 2017 · Comments

TWIPO hosts and cohosts interview Dr. Joshua Mendell, UT Southwestern Medical Center, who shares his knowledge with regard to the relationship between innate RNA biology and how it influences human disease.  

00:0000:00

Tags: Uncategorized

TWIPO #43 ~ Langerhans cell histiocytosis : Interview With Carl E. Allen

October 1st, 2014 · Comments

New York, NY -- In the most recent episode of This Week in Pediatric Oncology (TWiPO), the first podcast focusing on pediatric cancer research, co-hosts Dr. Edwin Horwitz (Nationwide Children’s Hospital), Dr. Nilay Shah (Nationwide Children’s Hospital),  Dr. Robyn Dennis (Nationwide Children's Hospital), interview Dr.  Carl E. Allen, (Texas Children’s Cancer and Hematology Centers) about his research in a rare pediatric blood disorder known as Langerhans cell histiocytosis (LCH).

Dr. Allen is Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology - Baylor College of Medicine, and the Co-Director of the Histiocytosis and Lymphoma Programs at Texas Children's Cancer and Hematology Centers.  His primary research is focused on the clinical and biologic aspects of LCH.  Along with Dr. Kenneth McClain, Dr. Carl Allen has developed the largest Histiocytosis Center in the world.  Dr. Allen has developed gene expression and proteomic strategies to analyze the identity and function of the cells that cause LCH.  The ultimate goal of these experiments is to identify genes, proteins, and pathways that may be used to diagnose and cure patients with LCH.  These experiments may also provide insight into dendritic cell biology and tumor immunology.

In this 20-minute episode, Dr. Allen gives an overview of LCH, as well as treatment and the future of LCH research.


 

00:0000:00

Tags: Uncategorized

TWIPO #40 ~ Advances in Neuroblastoma Research Meeting Recap: Advances in Understanding MYCN

July 10th, 2014 · Comments

New York – This Week in Pediatric Oncology presents the first of a series of interviews from the recent Advances in Neuroblastoma Research meeting, which was held in Cologne, Germany, in May. Co-hosts Dr. Nilay Shah (Nationwide Children’s Hospital) and Dr. Keri Stretby (Nationwide Children’s Hospital) caught up with two pediatric oncologists who’ve made significant advances in neuroblastoma research. In this 25-minute interview, Dr. Robert Seeger (Children's Hospital of Los Angeles) and Dr. Garrett Brodeur (Children’s Hospital of Philadelphia) discuss how the discovery of the MYCN gene 30 years ago has helped scientists better understand neuroblastoma and impacted treatment options.

00:0000:00

Tags: Uncategorized